Detection of Bence Jones myeloma and monitoring of myeloma chemotherapy using immunoassays specific for free immunoglobulin light chains.

Mead, G P; Carr-Smith, H D; Drayson, M T; Bradwell, A R

Mead, G P; Carr-Smith, H D; Drayson, M T; Bradwell, A R.

Affiliation

Mead GP; The Binding Site, PO Box 4073, Birmingham B29 6AT, UK.

Clin Lab ; 49(1-2): 25-7, 2003.

Article in En | MEDLINE | ID: mdl-12593472

Subject(s)

Antineoplastic Agents/therapeutic use; Bence Jones Protein/analysis; Immunoglobulin lambda-Chains/analysis; Multiple Myeloma/diagnosis; Multiple Myeloma/drug therapy; Half-Life; Humans; Immunoassay; Multiple Myeloma/metabolism; Sensitivity and Specificity; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Bence Jones Protein / Immunoglobulin lambda-Chains / Multiple Myeloma / Antineoplastic Agents Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Clin Lab Journal subject: TECNICAS E PROCEDIMENTOS DE LABORATORIO Year: 2003 Document type: Article Affiliation country: United kingdom Country of publication: Germany

Search on Google

Add to My VHL

XML

PubMed Links